IP Verse

Gip-Based Mixed Agonists For Treatment Of Metabolic Disorders And Obesity - EP2952202

The patent EP2952202 was granted to Indiana University Research And Technology on Oct 18, 2017. The application was originally filed on Jun 16, 2009 under application number EP15175377A. The patent is currently recorded with a legal status of "Opposition Rejected".

EP2952202

INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY
Application Number
EP15175377A
Filing Date
Jun 16, 2009
Status
Opposition Rejected
Mar 13, 2020
Grant Date
Oct 18, 2017
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

MAIWALDJul 17, 2018NEUEFEIND -

Patent Citations (16) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONWO2000GB01089
DESCRIPTIONWO2005GB00710
DESCRIPTIONWO2006US05020
DESCRIPTIONWO2006US17494
DESCRIPTIONWO2007US18415
DESCRIPTIONWO2008US53857
DESCRIPTIONUS6864069
DESCRIPTIONUS7355008
DESCRIPTIONUS7381408
DESCRIPTIONWO8705330
OPPOSITIONWO03082898
OPPOSITIONWO2008101017
OPPOSITIONWO2011094337
SEARCHUS2006003935
SEARCHWO03082898
SEARCHWO2006086769

Non-Patent Literature (NPL) Citations (59) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
DESCRIPTION- AHN ET AL., J. MED. CHEM., (2001), vol. 44, pages 3109 - 3116
DESCRIPTION- ANDREWS; TABOR, TETRAHEDRON, (1999), vol. 55, pages 11711 - 11743
DESCRIPTION- APLIN; WRISTON, CRC CRIT. REV. BIOCHEM., (1981), pages 259 - 306
DESCRIPTION- ARMOUR ET AL., EUR. J. IMMUNOL., (1999), vol. 29, page 2613
DESCRIPTION- BLACKWELL ET AL., ANGEW, CHEM., INT. ED., (1998), vol. 37, pages 3281 - 3284
DESCRIPTION- BURMEISTER ET AL., NATURE, (1994), vol. 372, page 379
DESCRIPTION- "Chemical Modifications of Proteins: History and Applications", BIOCONJUGATE CHEM., (1990), pages 1,2 - 12
DESCRIPTION- DAVIES, J. PEPTIDE. SCI, (2003), vol. 9, pages 471 - 501
DESCRIPTION- DIABETES, (2005), vol. 54, pages 2390 - 2395
DESCRIPTION- FRIEND ET AL., TRANSPLANTATION, (1999), vol. 68, page 1632
DESCRIPTION- FUKASE ET AL., BULL. CHEM. SOC. JPN., (1992), vol. 65, pages 2227 - 2240
DESCRIPTION- GHADIRI ET AL., J. AM. CHEM. SOC., (1990), vol. 112, pages 1630 - 1632
DESCRIPTION- GHADIRI ET AL., J. AM. CHEM. SOC., (1997), vol. 119, pages 9063 - 9064
DESCRIPTION- GOODMAN; SHAO, PURE APPL. CHEM, (1996), vol. 68, pages 1303 - 1308
DESCRIPTION- HARPP ET AL., J. ORG. CHEM., (1971), vol. 36, pages 73 - 80
DESCRIPTION- HENRY ET AL., BIOCHEMISTRY, (1997), vol. 36, pages 15568 - 15578
DESCRIPTION- IRWIN ET AL., DIABETOLOGIA, (2007), vol. 50, pages 1532 - 1540
DESCRIPTION- JACKSON ET AL., J. AM. CHEM. SOC., (1991), vol. 113, pages 9391 - 9392
DESCRIPTION- KINSTLER ET AL., ADV. DRUG. DELIVERY REV., (2002), vol. 54, pages 477 - 485
DESCRIPTION- LEWIS ET AL., J IMMUNOL., (2005), vol. 175, pages 6694 - 701
DESCRIPTION- LTEIF; MATHER, CAN. J. CARDIOL., (2004), vol. 20, no. B, pages 66B - 76B
DESCRIPTION- MATTEUCCI ET AL., TETRAHEDRON LETTERS, (2004), vol. 45, pages 1399 - 1401
DESCRIPTION- MAYER ET AL., J. PEPTIDE RES, (1998), vol. 51, pages 432 - 436
DESCRIPTION- MILLER, BIOCHEM BIOPHYS RES COMMUN, (1996), vol. 218, pages 377 - 382
DESCRIPTION- OSAPAY ET AL., J. MED. CHEM., (1997), vol. 40, pages 2241 - 2251
DESCRIPTION- OSAPAY; GOODMAN, J. CHEM. SOC. CHEM. COMMUN., (1993), pages 1599 - 1600
DESCRIPTION- PHELAN ET AL., J. AM. CHEM. SOC., (1997), vol. 119, pages 455 - 460
DESCRIPTION- POLINSKY ET AL., J. MED. CHEM., (1992), vol. 35, pages 4185 - 4194
DESCRIPTION- PREVIERO ET AL., BIOCHIM BIOPHYS ACTA, (1972), vol. 263, pages 7 - 13
DESCRIPTION- ROBERTS ET AL., ADV. DRUG DELIVERY REV., (2002), vol. 54, pages 459 - 476
DESCRIPTION- ROUTLEDGE ET AL., TRANSPLANTATION, (1995), vol. 60, page 847
DESCRIPTION- RUDINGER; JOST, EXPERIENTIA, (1964), vol. 20, pages 570 - 571
DESCRIPTION- SAN; SILVIUS, J PEPT RES, (2005), vol. 66, pages 169 - 180
DESCRIPTION- SAPSE ET AL., MOL. MED., (2002), vol. 8, no. 5, pages 251 - 262
DESCRIPTION- SAYERS ET AL., J BIOL CHEM., (2004), vol. 279, no. 34, pages 35320 - 5
DESCRIPTION- SCHAFMEISTER ET AL., J. AM. CHEM. SOC., (2000), vol. 122, pages 5891 - 5892
DESCRIPTION- SCHNOLZER ET AL., INT. J. PEPTIDE PROTEIN RES, (1992), vol. 40, pages 180 - 193
DESCRIPTION- SHIELDS ET AL., J. BIOL. CHEM., (1995), vol. 276, page 6591
DESCRIPTION- SHIELDS ET AL., J. BIOL. CHEM., (2001), vol. 276, page 6591
DESCRIPTION- SHIMOHIGASHI; STAMMER, INT JPEPT PROTEIN RES, (1982), vol. 19, pages 54 - 62
DESCRIPTION- SONDERMANN ET AL., NATURE, (2000), vol. 406, pages 267 - 273
DESCRIPTION- T. E. CREIGHTON, Proteins: Structure and Molecular Properties, W.H. FREEMAN & CO., (1983), pages 79 - 86
DESCRIPTION- UNSON ET AL., J. BIOL. CHEM., (1989), vol. 264, pages 789 - 794
DESCRIPTION- WALENSKY ET AL., SCIENCE, (2004), vol. 305, pages 1466 - 1470
DESCRIPTION- WARD; GHETIE, THERAPEUTIC IMMUNOLOGY, (1995), vol. 2, page 77
DESCRIPTION- WORMAN, HOWARD J., Alcoholic Liver Disease, COLUMBIA UNIVERSITY MEDICAL CENTER
DESCRIPTION- ZALIPSKY ET AL., ADV. DRUG DELIVERY REV., (1995), vol. 16, pages 157 - 182
DESCRIPTION- HASHIMOTO ET AL., "Synthesis of Palmitoyl Derivatives of Insulin and their Biological Activity", PHARMACUETICAL RES., (1989), vol. 6, no. 2, doi:doi:10.1023/A:1015992828666, pages 171 - 176, XP002050607
OPPOSITION- Martin Njogu MBUGUA, "Synthesis and binding studies of ring constrained glucagon analogues", Ph.D. thesis University of Nairobi, (20070000), pages 1 - 166, XP055505463
OPPOSITION- AHN et al., "A new approach to search for the bioactive conformation of glucagon: positional cyclization scanning", J. Med. Chem., (20010000), vol. 44, pages 3109 - 3116, XP002610716
OPPOSITION- MIRANDA et al., "Design and Synthesis of Conformationally Constrained Glucagon-Like Peptide-1 Derivatives with Increased Plasma Stability and Prolonged in Vivo Activity", J. Med. Chem., (20080500), vol. 51, pages 2758 - 2765, XP007909689
OPPOSITION- ALAÑA et al., "NMR and Alanine Scan Studies of Glucose-dependent Insulinotropic Polypeptide in Water", J. Biol. Chem., (20060000), vol. 281, pages 16370 - 16376, XP055505471
SEARCH- Anne-Marie Sapse ET AL, "The role of salt bridge formation in glucagon: an experimental and theoretical study of glucagon analogs and peptide fragments of glucagon", Molecular medicine (Cambridge, Mass.), United States, (20020501), pages 251 - 262, URL: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2039992&tool=pmcentrez&rendertype=abstract, XP055092921 [A] 1-18
SEARCH- HJORTH S A ET AL, "GLUCAGON AND GLUCAGON-LIKE PEPTIDE 1: SELECTIVE RECEPTOR RECOGNITION VIA DISTINCT PEPTIDE EPITOPES", JOURNAL OF BIOLOGICAL CHEMISTRY, THE AMERICAN SOCIETY OF BIOLOGICAL CHEMISTS, INC., BALTIMORE, MD, US, (19940101), vol. 269, no. 48, ISSN 0021-9258, pages 30121 - 30124, XP000919379 [A] 1-18
SEARCH- UNSON C G ET AL, "GLUCAGON ANTAGONISTS: CONTRIBUTION TO BINDING AN ACTIVITY OF THE AMINO-TERMINAL SEQUENCE 1-5, POSITION 12, AND THE PUTATIVE ALPHA-HELICAL SEGMENT 19-27", JOURNAL OF BIOLOGICAL CHEMISTRY, THE AMERICAN SOCIETY OF BIOLOGICAL CHEMISTS, INC., BALTIMORE, MD, US, (19890115), vol. 264, no. 2, ISSN 0021-9258, pages 789 - 794, XP000572345 [A] 1-18
SEARCH- UNSON C G ET AL, "The Role of Histidine-1 in Glucagon Action", ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, ACADEMIC PRESS, US, vol. 300, no. 2, doi:10.1006/ABBI.1993.1103, ISSN 0003-9861, (19930201), pages 747 - 750, (19930201), XP024753421 [A] 1-18
SEARCH- MCKEE R L ET AL, "RECEPTOR BINDING AND ADENYLATE CYCLASE ACTIVITIES OF GLUCAGON ANALOGUES MODIFIED IN THE N-TERMINAL REGION", BIOCHEMISTRY, AMERICAN CHEMICAL SOCIETY, (19860101), vol. 25, doi:10.1021/BI00355A031, ISSN 0006-2960, pages 1650 - 1656, XP002495828 [A] 1-18
SEARCH- SUIERAS-DIAZ J ET AL, "Structure-Activity Studies on the N-Terminal Region of Glucagon", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY, US, (19840101), vol. 27, doi:10.1021/JM00369A014, ISSN 0022-2623, pages 310 - 315, XP003027642 [A] 1-18
SEARCH- TRIVEDI DEV ET AL, "Design and synthesis of conformationally constrained glucagon analogues", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY, US, vol. 43, no. 9, doi:10.1021/JM990559D, ISSN 0022-2623, (20000504), pages 1714 - 1722, (20000406), XP002610717 [A] 1-18

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents